Stanford Department of Electrical Engineering

Immix Biopharma Subsidiary Nexcella Announces Dr. Michaela Liedtke, Stanford Medicine Cancer Center Hematology Program Lead and Co-Director Stanford Amyloid Center, Joins Scientific Advisory Board

Retrieved on: 
Thursday, October 26, 2023

LOS ANGELES, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us”), announced that effective today, Dr. Michaela Liedtke has joined ImmixBio subsidiary Nexcella Scientific Advisory Board.

Key Points: 
  • LOS ANGELES, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us”), announced that effective today, Dr. Michaela Liedtke has joined ImmixBio subsidiary Nexcella Scientific Advisory Board.
  • Dr. Liedtke brings decades of experience in hematology/oncology clinical trials, clinical trial design, and thought leadership to Nexcella.
  • “We need more effective treatments to improve the outcomes for patients with relapsed/refractory AL amyloidosis and relapsed/refractory multiple myeloma,” said Dr. Liedtke.
  • We are excited to be working with Dr. Liedtke.”
    Dr. Liedtke is the Stanford University Medicine Cancer Center Program Lead, Hematology; Co-Director, Stanford Amyloid Center; Medical Director, Stanford Adolescent and Young Adult Program; and Member Leukemia Committee, Southwest Oncology Group.

Nexcella Announces Dr. Michaela Liedtke, Stanford Medicine Cancer Center Hematology Program Lead and Co-Director Stanford Amyloid Center, Joins Scientific Advisory Board

Retrieved on: 
Thursday, October 26, 2023

LOS ANGELES, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Nexcella, Inc. (“Nexcella”, “Company”, “We” or “Us”), announced that effective today, Dr. Michaela Liedtke has joined the Nexcella Scientific Advisory Board.

Key Points: 
  • LOS ANGELES, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Nexcella, Inc. (“Nexcella”, “Company”, “We” or “Us”), announced that effective today, Dr. Michaela Liedtke has joined the Nexcella Scientific Advisory Board.
  • Dr. Liedtke brings decades of experience in hematology/oncology clinical trials, clinical trial design, and thought leadership to Nexcella.
  • We are excited to be working with Dr. Liedtke.”
    Dr. Liedtke is the Stanford University Medicine Cancer Center Program Lead, Hematology; Co-Director, Stanford Amyloid Center; Medical Director, Stanford Adolescent and Young Adult Program; and Member Leukemia Committee, Southwest Oncology Group.
  • Dr. Liedtke completed her fellowship at Stanford University Medical Center and Memorial Sloan-Kettering Cancer Center, residency at the Albert Einstein College of Medicine, and received her medical degree from Medizinische Hochschule Hannover.

Volvo Group: Professor Lars Eriksson awarded with Håkan Frisingers scholarship for his significant contributions in transportation research

Retrieved on: 
Thursday, September 21, 2023

GOTHENBURG, Sweden, Sept. 21, 2023 /PRNewswire/ -- Håkan Frisinger Award for Excellence in Transportation Research awards its 2023 scholarship to Professor Lars Eriksson at Linköpings University.

Key Points: 
  • GOTHENBURG, Sweden, Sept. 21, 2023 /PRNewswire/ -- Håkan Frisinger Award for Excellence in Transportation Research awards its 2023 scholarship to Professor Lars Eriksson at Linköpings University.
  • The scholarship rewards Lars Eriksson for his strong scientific record and his significant contribution to the transport industry.
  • Lars Eriksson is a professor in Vehicular Systems at the Department of Electrical Engineering at Linköping University.
  • He is now rewarded the Håkan Frisinger Award for Excellence in Transportation Research for his contributions.

David Maman and Divya Chander to Keynote CharmHealth Third Annual Innovation Challenge & Showcase

Retrieved on: 
Friday, August 11, 2023

CharmHealth , a leading provider of healthcare technology solutions, today announced that Binah.ai CEO and Founder David Maman and Divya Chander , chair of neuroscience, faculty in medicine at Singularity University, will be the keynote speakers for the 2023 Innovation Challenge .

Key Points: 
  • CharmHealth , a leading provider of healthcare technology solutions, today announced that Binah.ai CEO and Founder David Maman and Divya Chander , chair of neuroscience, faculty in medicine at Singularity University, will be the keynote speakers for the 2023 Innovation Challenge .
  • “We are delighted to welcome David and Divya as keynote speakers at this year’s Innovation Challenge,” said Pramila Srinivasan , Ph.D., CEO of CharmHealth.
  • To participate in the CharmHealth Innovation Challenge, interested individuals, startups and organizations can submit their proposals through the official challenge website at https://charmhealthchallenge.com/ .
  • For more information about the CharmHealth Innovation Challenge, including guidelines, eligibility criteria, and important dates, please visit the challenge website or contact [email protected] .

Pure Wafer’s Dr. Ardy Sidhwa Named 2023 Inductee to Arkansas Academy of Electrical Engineering

Retrieved on: 
Monday, June 19, 2023

14 finalists, including Dr. Sidhwa, were inducted into the Academy at the AAEE’s annual awards banquet in Fayetteville, Arkansas.

Key Points: 
  • 14 finalists, including Dr. Sidhwa, were inducted into the Academy at the AAEE’s annual awards banquet in Fayetteville, Arkansas.
  • The Arkansas Academy of Electrical Engineering was founded on December 8, 1980, by the Department of Electrical Engineering.
  • View the full release here: https://www.businesswire.com/news/home/20230618712186/en/
    The 2023 inductees are recognized for their work and their service to the field of electrical engineering, including their service to the Arkansas Electrical Engineering Department and who support the field of Electrical Engineering both as practitioners and as citizens.
  • “We are thrilled to learn of Ardy’s induction into the Arkansas Academy of Electrical Engineering,” commented S. Mark Borowicz, CEO, Pure Wafer.

BTM Group Sponsors 2023 Columbia University's China Prospects Conference, Featuring Founder Yu Liu as Panelist

Retrieved on: 
Thursday, April 6, 2023

NEW YORK, April 6, 2023 /PRNewswire/ -- BTM Group, a multinational enterprise group covering legal services, EB-5 services, investment and financing management, private equity funds, real estate development, proudly sponsored the 2023 Columbia University's China Prospects Conference hosted at the Low Library, Columbia University on April 2, 2023.

Key Points: 
  • NEW YORK, April 6, 2023 /PRNewswire/ -- BTM Group, a multinational enterprise group covering legal services, EB-5 services, investment and financing management, private equity funds, real estate development, proudly sponsored the 2023 Columbia University's China Prospects Conference hosted at the Low Library, Columbia University on April 2, 2023.
  • BTM's founder Yu Liu was invited to join the ESG panel discussion.
  • "ESG represents a vital aspect of social awareness and responsibility," BTM Group's founder, Yu Liu offered his perspectives while discussing the ESG subject in the panel.
  • "BTM Group's generous sponsorship of Columbia University's China Prospects Conference has been instrumental in creating a valuable platform for discussion and exploration of China's future development prospects," said Lin Yuan Chun Yu, President of the Columbia University Chinese Students and Scholars Association (CUCSSA).

Golden State Dermatology Expands South in the San Francisco Bay Area

Retrieved on: 
Wednesday, December 14, 2022

LOS GATOS, Calif., Dec. 13, 2022 /PRNewswire/ -- Golden State Dermatology (GSD) is pleased to announce the opening of a new location in Los Gatos, CA. The new location expands GSD's services to the South Bay Area and Santa Cruz County residents.

Key Points: 
  • The new location expands GSD's services to the South Bay Area and Santa Cruz County residents.
  • Dr. Soohoo is board certified in general and pediatric dermatology and is also highly-skilled in many cosmetic dermatology procedures.
  • To learn more about Golden State Dermatology, and its newest Los Gatos location, please visit GoldenStateDermatology.com
    In the midst of health care consolidation, Golden State Dermatology (GSD) was founded to maintain a relatively independent model of practice.
  • GSD is physician-owned and led and is rapidly growing with over 60 providers in the San Francisco Bay Area and California's Central Valley.

Verana Health Launches Neurology Qdata™ Insights Offerings at American Academy of Neurology Annual Meeting

Retrieved on: 
Monday, April 4, 2022

SAN FRANCISCO, April 4, 2022 /PRNewswire/ -- Verana Health®—a digital health company that delivers quality drug lifecycle and medical practice insights from an exclusive real-world data network—today announced the launch of its first Neurology Qdata™, available through Verana Health's real-world evidence service offerings. Neurology Qdata for life sciences companies will be featured at the American Academy of Neurology's (AAN) 2022 Annual Meeting alongside Verana Health's solutions for neurologists, including a new Quality Measures Dashboard for the Axon Registry® and Verana Trial Connect for physicians interested in participating in clinical trials. The AAN's Annual Meeting is in Seattle from April 2–7.

Key Points: 
  • Neurology Qdata for life sciences companies will be featured at the American Academy of Neurology 's (AAN) 2022 Annual Meeting alongside Verana Health's solutions for neurologists, including a new Quality Measures Dashboard for the Axon Registry and Verana Trial Connect for physicians interested in participating in clinical trials.
  • Following the release of Qdata SMA, Verana Health expects to release additional Neurology Qdata modules for neurological diseases including Parkinson's Disease, multiple sclerosis, Neuromyelitis Optica Spectrum Disorder (NMOSD), and others.
  • "The Axon Registry empowers neurologists by giving them deeper insights into their quality of care and our partnership with Verana Health is key to helping advance the specialty of neurology through the therapeutic insights that can be unlocked with the help of Verana Health's Neurology Qdata."
  • Qdata SMA provides life sciences companies with real-world insights into the natural history of disease, treatments, and outcomes for SMA patients.

MINDCURE Hires Dr. Clare Purvis from Headspace to the position of Chief Product Officer to Advance Mental Health Digital Therapeutics Platform

Retrieved on: 
Thursday, February 3, 2022

She currently serves as a Clinical Advisory Board member at Brightline, which provides a technology-driven approach to pediatric behavioral health.

Key Points: 
  • She currently serves as a Clinical Advisory Board member at Brightline, which provides a technology-driven approach to pediatric behavioral health.
  • "It's a pivotal and proud moment in the trajectory of MINDCURE as we welcome Dr. Purvis to the team.
  • About Mind Cure Health Inc.
    MINDCURE is a life sciences company focused on innovating and commercializing new ways to promote healing and improve mental health.
  • The company is developing digital therapeutics technology and researching psychedelic compounds to support access to safe, evidence-based psychedelic-assisted therapies globally.

Raven Industries Gives $150,000 to South Dakota Mines for New Scholarship and Avionics Upgrades

Retrieved on: 
Wednesday, October 20, 2021

South Dakota Mines Department of Electrical Engineering has received $150,000 from Raven Industries (NASDAQ:RAVN) to support the universitys new minor in avionics.

Key Points: 
  • South Dakota Mines Department of Electrical Engineering has received $150,000 from Raven Industries (NASDAQ:RAVN) to support the universitys new minor in avionics.
  • View the full release here: https://www.businesswire.com/news/home/20211020005181/en/
    Two South Dakota Mines students use the university flight simulator in the Department of Electrical Engineering.
  • (Photo: Business Wire)
    We are grateful for the ongoing partnership the University has had with Raven Industries, says Mines President Jim Rankin, Ph.D.
  • For decades, Raven has enjoyed a rewarding relationship with South Dakota Mines, and we know first-hand the value of their education, learning experiences and programs, commented Dan Rykhus, President & CEO of Raven Industries.